Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis
Acta Biomaterialia · 2024-03 · 176 · 417-431
DOI: 10.1016/j.actbio.2024.01.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-03. Verfasst von Paul Humbert und 10 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 122…. Hauptthemen laut MEDLINE: Osteogenesis, Calcium Phosphates. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conseil Régional des Pays de la Loire, Generalitat de Catalunya, Institució Catalana de Recerca i Estudis Avançats.
Abstract (Originalsprache)
Human mesenchymal stromal cells (hMSCs) seeded on calcium phosphate (CaP) bioceramics are extensively explored in bone tissue engineering and have recently shown effective clinical outcomes. In previous pre-clinical studies, hMSCs-CaP-mediated bone formation was preceded by osteoclastogenesis at the implantation site. The current study evaluates to what extent phase composition of CaPs affects the osteoclast response and ultimately influence bone formation. To this end, four different CaP bioceramics were used, hydroxyapatite (HA), β-tricalcium phosphate (β-TCP) and two biphasic composites of HA/β-TCP ratios of 60/40 and 20/80 respectively, for in vitro osteoclast differentiation and correlation with in vivo osteoclastogenesis and bone formation. All ceramics allowed osteoclast formation in vitro from mouse and human precursors, except for pure HA, which significantly impaired their maturation. Ectopic implantation alongside hMSCs in subcutis sites of nude mice revealed new bone formation at 8 weeks in all conditions with relative amounts for β-TCP > biphasic CaPs > HA. Surprisingly, while hMSCs were essential for osteoinduction, their survival did not correlate with bone formation. By contrast, the degree of early osteoclastogenesis (2 weeks) seemed to define the extent of subsequent bone formation. Together, our findings suggest that the osteoclastic response could be used as a predictive marker in hMSC-CaP-based bone regeneration and strengthens the need to understand the underlying mechanisms for future biomaterial development. STATEMENT OF SIGNIFICANCE: The combination of mesenchymal stromal cells (MSCs) and calcium phosphate (CaP) materials has demonstrated its safety and efficacy for bone regeneration in clinical trials, despite our insufficient understanding of the underlying biological mechanisms. Osteoclasts were previously suggested as key mediators between the early inflammatory phase following biomaterial implantation and the subsequent bone formation. Here we compared the affinity of osteoclasts for various CaP materials with different ratios of hydroxyapatite to β-tricalcium phosphate. We found that osteoclast formation, both in vitro and at early stages in vivo, correlates with bone formation when the materials were implanted alongside MSCs in mice. Surprisingly, MSC survival did not correlate with bone formation, suggesting that the number or phenotype of osteoclasts formed was more important.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1229, RMeS, Regenerative Medicine and Skeleton, University of Nantes, Oni…
- Karl Donath Laboratory for Hard Tissue and Biomaterial Research, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria; Division of Pharmacology and Toxicology, Department of Pharmaceutical Scien…
- Regenerative Medicine Institute, School of Medicine and Biomedical Engineering, School of Engineering, University of Galway, Galway, Ireland.
- Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, Universitat Politècnica de Catalunya, Barcelona, Spain; Research Centre in Multiscale Science and Engineering, Un…
- Division of Pharmacology and Toxicology, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
- INSERM, UMR 1238, Phy-OS, Bone Sarcoma and Remodeling of Calcified Tissues, School of Medicine, University of Nantes, Nantes, France; INSERM, UMR 1214, ToNIC, CHU Purpan, Université Paul Sabatier, Toulouse, France. Elec…
Förderung
- Conseil Régional des Pays de la Loire
- Generalitat de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
- Horizon 2020 Framework Programme
- Ministerio de Ciencia e Innovación
- H2020 Marie Skłodowska-Curie Actions
- Campus France
- Horizon 2020
Zitieren
APA
Humbert, P., Kampleitner, C., De Lima, J., Brennan, M. Á., Lodoso-Torrecilla, I., Sadowska, J. M., Blanchard, F., Canal, C., Ginebra, M. P., Hoffmann, O., & Layrolle, P. (2024). Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis. Acta Biomaterialia, 176, 417-431. https://doi.org/10.1016/j.actbio.2024.01.022
Vancouver
Humbert P, Kampleitner C, De Lima J, Brennan MÁ, Lodoso-Torrecilla I, Sadowska JM, et al. Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis. Acta Biomaterialia. 2024;176:417-431. doi:10.1016/j.actbio.2024.01.022
BibTeX
@article{Humbert2024,
author = {Humbert, Paul and Kampleitner, Carina and De Lima, Julien and Brennan, Meadhbh Á and Lodoso-Torrecilla, Irene and Sadowska, Joanna Maria and Blanchard, Frédéric and Canal, Cristina and Ginebra, Maria-Pau and Hoffmann, Oskar and Layrolle, Pierre},
title = {Phase composition of calcium phosphate materials affects bone formation by modulating osteoclastogenesis},
journal = {Acta Biomaterialia},
year = {2024},
volume = {176},
pages = {417--431},
doi = {10.1016/j.actbio.2024.01.022}
}
EUVIMED